ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Exagen Diagnostics, Inc. announces that it will offer an oral presentation from a multi-site clinical study of genomic markers for breast cancer on Saturday, June 2nd.
ABSTRACT TITLE: "Validation of genomic markers that predict distant recurrence risk via FISH assays in women with early stage breast cancer"
